Get started
Author

Maria Cristina Figueroa Magalhães

Observed names: M.C. Magalhães, M.C.F. Magalhães, MARIA CRISTINA FIGUEROA MAGALHÃES, Magalhães, Maria Cristina Figueroa, Maria Cristina Figueiroa Magalhães, Maria Cristina Figueroa, Maria Cristina Figueroa Magalhaes, Maria Cristina Figueroa-Magalhaes, Maria Cristina Figueroa-Magalhães
Observed institutions: Pontifical Catholic University of Puerto Rico, F. Hoffmann-La Roche AG, Johns Hopkins University, Pontifícia Universidade Católica do Paraná, Universidade de São Paulo, Genentech, Johns Hopkins Medicine, Instituto do Câncer do Estado de São Paulo, Hospital de Câncer de Barretos, Hospital Universitário Evangélico de Curitiba, Hospital Universitário Cajuru, Faculdade Evangélica do Paraná, Sidney Kimmel Comprehensive Cancer Center, Celgene (United States), Universidade Federal do Estado do Rio de Janeiro
ORCID: 0000-0001-7748-8399
Observed ORCID: 0000-0001-7748-8399
OpenAlex ID: A5053238171
Treatment of HER2-positive breast cancer
2013 · Maria Cristina Figueroa-Magalhães, Danijela Jelovac, et al. · The Breast · 294
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
2016 · Ashley Cimino-Mathews, Sangita Verma, et al. · American Journal of Clinical Pathology · 95
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer
2016 · Hyun-seok Kim, Christopher B. Umbricht, et al. · Journal of Clinical Oncology · 56
Pathologic response rates in HER2-low versus HER2-zero early breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis
2025 · Francisco Cezar Aquino de Moraes, Caio Henrique Duarte de Castro Ribeiro, et al. · Breast Cancer Research · 21
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials
2024 · Francisco Cezar Aquino de Moraes, Gustavo de Oliveira Almeida, et al. · Journal of Personalized Medicine · 12
PDF
Effects of AKT Inhibitors for PIK3CA/AKT1/PTEN-Altered Advanced or Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials
2025 · Francisco Cezar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, et al. · Clinical Breast Cancer · 9
Value of Systemic Staging in Asymptomatic Early Breast Cancer
2018 · Gregório Pinheiro Soares, Allan Andresson Lima Pereira, et al. · Revista Brasileira Ginecologia e Obstetrícia · 9
PDF
Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor–Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study
2025 · Daniele Assad-Suzuki, Danielle Laperche-Santos, et al. · JCO Global Oncology · 8
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials
2024 · Francisco Cezar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, et al. · European Journal of Clinical Pharmacology · 8
Ligand-Mediated Nanomedicines Against Breast Cancer: A Review
2022 · Guilherme F Picheth, Fernando A de O Ganzella, et al. · Nanomedicine · 8
RETRACTED: Omitting axillary lymph node dissection is associated with an increased risk of regional recurrence in early stage breast cancer: a systematic review and meta-analysis of randomized clinical trials
2024 · Jorge Henrique Cavalcanti Orestes Cardoso, Isabella Christina Amaral de Lara, et al. · Clinical Breast Cancer · 7
Statins and prognosis of female breast cancer: a meta-analysis
2025 · Francisco Cezar Aquino de Moraes, Pedro Henrique de Souza Wagner, et al. · Clinical & Translational Oncology · 6
Adjuvant Chemotherapy in Early Triple-Negative Breast Cancer (T1a-c N0M0): A Systematic Review and Meta-Analysis
2025 · Francisco Cezar Aquino de Moraes, Pedro Henrique de Souza Wagner, et al. · Clinical Breast Cancer · 5
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer
2020 · Eric Xie, Maya M. Lapinski, et al. · Breast Cancer Research and Treatment · 5
Does Epstein–Barr Virus Contribute to Breast Cancer Risk Worldwide? A Systematic Review and Meta-Analysis
2025 · Francisco Cezar Aquino de Moraes, Pedro Henrique de Souza Wagner, et al. · Clinical Breast Cancer · 4
Bone-modifying agents as adjuvant therapy for early-stage breast cancer.
2012 · Maria Cristina Figueroa-Magalhães, Robert S Miller · PubMed · 4
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor–Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil
2025 · Romualdo Barroso-Sousa, Danielle Laperche-Santos, et al. · JCO Global Oncology · 3
An estimation model for Oncotype DX recurrence score using routine histopathologic variables.
2014 · Hyunseok Kim, Christopher Umbricht, et al. · Journal of Clinical Oncology · 3
Cirrose hepática e hemocromatose neonatal secundária associadas à tirosinemia tipo 1: relato de um caso e diagnóstico diferencial com hemocromatose primária hereditária
2006 · Ana Paula Camargo Martins, Maria Carolina Pospissil, et al. · Jornal Brasileiro de Patologia e Medicina Laboratorial · 3
PDF
Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis
2025 · Pedro Henrique de Souza Wagner, Gustavo Tadeu Freitas Uchôa Matheus, et al. · British Journal of Cancer · 2
Employment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer
2025 · Daniele Assad‐Suzuki, Luciana Castro Garcia Landeiro, et al. · Cancer Medicine · 2
PDF
HLA-I and breast cancer prognosis: A systematic review and meta-analysis
2024 · Francisco Cezar Aquino de Moraes, Jorge Henrique Cavalcanti Orestes Cardoso, et al. · Human Immunology · 2
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer
2025 · Danielle Laperche-Santos, Daniele Assad-Suzuki, et al. · Breast Cancer Research and Treatment · 1
PDF
Non-metastatic breast cancer in older patients in Brazil: Adherence to endocrine therapy, quality of life, and sexual health
2025 · Daniele Assad-Suzuki, Andrea Kazumi Shimada, et al. · Journal of Geriatric Oncology · 1
Bilateral Gonadal Dysgerminoma in a Phenotypic Female With 46,XY Disorder of Sexual Development: A Case Report
2023 · Ricardo Pasquini Neto, Maria Letícia Carnielli Tebet, et al. · Cureus · 1
PDF
Works count: 60
Citation count: 572
H-index: 8
I10-index: 5
Year
Topic
Type